trial · primary record
Probiotics combined with neoadjuvant chemoimmunotherapy
NSCLC Diagnosed by Histology or Cytology
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 46 |
| Primary completion | 2027-12-23 |
| Primary endpoint | Major pathological response |
| Registry ID | NCT07534033 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:07.756Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07534033
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.